-+ 0.00%
-+ 0.00%
-+ 0.00%

VISTAGEN THERAPEUTICS INC - PALISADE-4 PHASE 3 TRIAL RESULTS EXPECTED IN FIRST HALF OF 2026

Reuters·06/02/2025 12:30:00

Please log in to view news